Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

1.

Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study.

Ahrens W, Hagemeier C, Mühlbauer B, Pigeot I, Püntmann I, Reineke A, Steinbach M, Timm J.

Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1298-307.

PMID:
17957709
[PubMed - indexed for MEDLINE]
2.

Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension.

Delea TE, Taneja C, Moynahan A, Thomas SK, Frech-Tamas F, Oster G.

Am J Health Syst Pharm. 2007 Jun 1;64(11):1187-96.

PMID:
17519461
[PubMed - indexed for MEDLINE]
3.

Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations.

Pigeot I, Ahrens W.

Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):215-23. doi: 10.1002/pds.1545.

PMID:
18200610
[PubMed - indexed for MEDLINE]
4.

CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction.

Goryachkina K, Burbello A, Boldueva S, Babak S, Bergman U, Bertilsson L.

Eur J Clin Pharmacol. 2008 Dec;64(12):1163-73. doi: 10.1007/s00228-008-0525-3. Epub 2008 Jul 22.

PMID:
18648788
[PubMed - indexed for MEDLINE]
5.
6.

Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co-medication in Taiwan.

Gau CS, Chang IS, Lin Wu FL, Yu HT, Huang YW, Chi CL, Chien SY, Lin KM, Liu MY, Wang HP.

Pharmacoepidemiol Drug Saf. 2007 Jan;16(1):86-95.

PMID:
17006967
[PubMed - indexed for MEDLINE]
7.

Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).

Spies C, Farzaneh-Far R, Na B, Kanaya A, Schiller NB, Whooley MA.

Am J Cardiol. 2009 Oct 1;104(7):883-9. doi: 10.1016/j.amjcard.2009.05.027.

PMID:
19766751
[PubMed - indexed for MEDLINE]
8.
9.

Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy.

Poluzzi E, Strahinja P, Lanzoni M, Vargiu A, Silvani MC, Motola D, Gaddi A, Vaccheri A, Montanaro N.

Eur J Clin Pharmacol. 2008 Apr;64(4):425-32. doi: 10.1007/s00228-007-0428-8. Epub 2008 Jan 5.

PMID:
18176802
[PubMed - indexed for MEDLINE]
10.

Effects of antiepileptic drug substitutions on epileptic events requiring acute care.

Rascati KL, Richards KM, Johnsrud MT, Mann TA.

Pharmacotherapy. 2009 Jul;29(7):769-74. doi: 10.1592/phco.29.7.769.

PMID:
19558250
[PubMed - indexed for MEDLINE]
11.

beta-Blocker therapy in veterans with asthma or chronic obstructive pulmonary disease.

Barnett MJ, Milavetz G, Kaboli PJ.

Pharmacotherapy. 2005 Nov;25(11):1550-9.

PMID:
16232018
[PubMed - indexed for MEDLINE]
12.
13.

Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits.

Dahlström U, Berglund U, Karlsson E.

Acta Med Scand. 1980;207(3):167-71.

PMID:
6102838
[PubMed - indexed for MEDLINE]
14.

Brand versus generic alendronate: gastrointestinal effects measured by resource utilization.

Halkin H, Dushenat M, Silverman B, Shalev V, Loebstein R, Lomnicky Y, Friedman N.

Ann Pharmacother. 2007 Jan;41(1):29-34. Epub 2006 Dec 26.

PMID:
17190847
[PubMed - indexed for MEDLINE]
15.

Case-crossover study of hospitalization for acute hepatitis in Chinese herb users.

Lee CH, Wang JD, Chen PC.

J Gastroenterol Hepatol. 2008 Oct;23(10):1549-55. doi: 10.1111/j.1440-1746.2008.05511.x. Epub 2008 Aug 20.

PMID:
18717756
[PubMed - indexed for MEDLINE]
16.

Topical beta blockers in asthmatic patients-is it safe?

Kaiserman I, Fendyur A, Vinker S.

Curr Eye Res. 2009 Jul;34(7):517-22.

PMID:
19899964
[PubMed - indexed for MEDLINE]
17.

Healthcare utilization and costs of patients with rosacea in an insured population.

Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.

J Drugs Dermatol. 2008 Jan;7(1):41-9.

PMID:
18246697
[PubMed - indexed for MEDLINE]
18.

[Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].

Laux G, Szecsenyi J, Miksch A, Grün B, Gutscher A, Grün B, Rosemann T, Kühlein T.

Med Klin (Munich). 2009 Feb 15;104(2):108-13. doi: 10.1007/s00063-009-1028-4. Epub 2009 Feb 26. German.

PMID:
19242661
[PubMed - indexed for MEDLINE]
19.

Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.

Bangalore S, Messerli FH, Cohen JD, Bacher PH, Sleight P, Mancia G, Kowey P, Zhou Q, Champion A, Pepine CJ; INVEST Investigators.

Am Heart J. 2008 Aug;156(2):241-7. doi: 10.1016/j.ahj.2008.02.023.

PMID:
18657652
[PubMed - indexed for MEDLINE]
20.

Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.

Bangalore S, Sawhney S, Messerli FH.

J Am Coll Cardiol. 2008 Oct 28;52(18):1482-9. doi: 10.1016/j.jacc.2008.06.048.

PMID:
19017516
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk